Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar Gel in Ocular Sarcoidosis
NCT02725177Completed
- Sponsor
- Cleveland Clinic
- Start
- Jul 2016
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial of repository corticotropin injection in ocular sarcoidosis, sponsored by Cleveland Clinic. Primary endpoint: Percentage of Patients With Clinically Significant Improvement in Visual Acuity at 24 weeks. Started Jul 2016; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
ocular sarcoidosis
Beyond the preview
Go deeper on NCT02725177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02725177.